VRTX

VRTX Debt Repayment

-$2.80MTTM · USD

Period ending:

VRTX FY Debt RepaymentUSD
VRTX FY Debt Repayment1991-12-31: -$1.00M1992-12-31: -$1.30M1993-12-31: -$2.00M1994-12-31: -$1.90M1995-12-31: $600.00K1996-12-31: $1.50M1997-12-31: -$1.30M1998-12-31: $1.40M1999-12-31: -$2.70M2000-12-31: $499.54M2001-12-31: -$23.64M2002-12-31: $1.01M2003-12-31: $25.51M2004-12-31: -$12.56M2005-12-31: $0.002006-12-31: $0.002007-12-31: -$42.10M2008-12-31: $258.61M2009-12-31: $149.77M2010-12-31: $391.65M2011-12-31: -$155.00M2012-12-31: -$21.49M2013-12-31: -$83.74M2014-12-31: $272.46M2015-12-31: $3.33M2016-12-31: -$6.86M2017-12-31: -$284.67M2018-12-31: -$12.55M2019-12-31: -$29.14M2020-12-31: -$29.02M2021-12-31: -$18.70M2022-12-31: -$85.50M2023-12-31: -$44.90M2024-12-31: -$33.60M2025-12-31: -$5.40M$499.54M-$284.67M
1991-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

VRTX debt repayment history

Cash used to repay outstanding debt. The available annual fiscal periods series contains 35 observations from Dec 31, 1991 to Dec 31, 2025.

Vertex Pharmaceuticals Debt Repayment — Annual fiscal periods (USD)
Period endingDebt Repayment (USD)
-5,400,000
-33,600,000
-44,900,000
-85,500,000
-18,700,000
-29,024,000
-29,139,000
-12,548,000
-284,670,000
-6,856,000
3,327,000
272,464,000
-83,742,000
-21,488,000
-155,000,000
391,645,000
149,771,000
258,610,000
-42,102,000
0
0
-12,563,000
25,509,000
1,014,000
-23,635,000
499,538,000
-2,700,000
1,400,000
-1,300,000
1,500,000
600,000
-1,900,000
-2,000,000
-1,300,000
-1,000,000

Compare debt repayment

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.